Clinical parameters | HR (beats/minute) | MAP (mmHg) | CVP (mmHg) | CI (L/minute/m2) |
---|
Baseline | | | | |
CONTROL | 57 ± 21 | 88 ± 33 | 5 ± 2 | 3.8 ± 0.5 |
SEVO | 65 ± 11 | 71 ± 14 | 4 ± 2 | 3.8 ± 0.7 |
1-hour ROSC | | | | |
CONTROL | 116 ± 26 | 82 ± 8 | 8 ± 3 | 4.4 ± 1.3 |
SEVO | 108 ± 11 | 74 ± 19 | 7 ± 2 | 5.1 ± 0.9 |
2-hour ROSC | | | | |
CONTROL | 95 ± 19 | 76 ± 17 | 6 ± 1 | 4.4 ± 1.0 |
SEVO | 109 ± 12 | 81 ± 13 | 6 ± 1 | 5.7 ± 1.7 |
4-hour ROSC | | | | |
CONTROL | 97 ± 21 | 76 ± 16 | 8 ± 2 | 5.0 ± 1.7 |
SEVO | 101 ± 19 | 74 ± 13 | 7 ± 2 | 5.5 ± 1.6 |
24-hour ROSC | | | | |
CONTROL | 75 ± 15 | 65 ± 9 | 8 ± 3 | 4.0 ± 0.8 |
SEVO | 69 ± 15 | 69 ± 15 | 7 ± 2 | 3.4 ± 0.6 |
- Hemodynamic data were determined at baseline and 1, 2, 4 and 24 hours after return of spontaneous circulation (ROSC) in the propofol (CONTROL) and sevoflurane (SEVO) groups. Data are means ± SD. Heart rate (HR), mean arterial pressure (MAP), central venous pressure (CVP) and cardiac index (CI) did not differ significantly between groups after we applied the Bonferroni correction for repeated time measurements using two-way analysis of variance. Cardiac index was calculated as the ratio of cardiac output to body surface area (body surface area = 0.0734 × (body weight in kilograms)0.656) [10].